The Section of Molecular Pathology focuses on the elucidation of the molecular basis and genetic pathways of human neoplasms, with the objectives of correlating histologically recognised phenotypes with genotypes, and identifying reliable molecular markers for tumour classification and tumour progression. The Section of Molecular Pathology is also responsible for the publication of the 4th edition of the WHO Classification of Tumours Series (WHO Blue Books), which are accepted and used worldwide.
The research program of the Section of Molecular Pathology is a key element in the Agency's work on the elucidation of mechanisms of carcinogenesis. The WHO Blue Books contribute to the Agency's mission of monitoring global cancer occurrence, since without clearly defined histopathological and genetic diagnostic criteria, epidemiological and clinical studies are difficult to conduct. The section receives funding from the Foundation for Promotion of Cancer Research, Japan, and the MEDIC Foundation, Switzerland.
